Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Jupiter Neurosciences doses...
Cerevance reports Solengepr...
AgelessRx introduces GHK-Cu...
ProMIS appoints new chief c...
Shift uses AI virtual cells...
Jupiter Neurosciences doses...
Cerevance reports Solengepr...
AgelessRx introduces GHK-Cu...
ProMIS appoints new chief c...
Shift uses AI virtual cells...
Investment
Investment
Investment
Tiny Health lands $33m to read the gut for life
Biotech
Ecosystem
Investment
Investment
The case for regeneration over slowing decline
Biotech
Investment
Investment
Genentech pays $100m upfront for Alector’s AL050
The Parkinson’s enzyme therapy is still heading toward the clinic, and the deal could grow by
Ecosystem
Investment
Investment
Longevity investors put evidence to the test
AI/Digital
Investment
Investment
UCLA lands $25m to test dementia AI tools
Biotech
Investment
Investment
China’s longevity biotech head start
Ecosystem
Features
Investment
Investment
‘Show me the error bars before you sell me longevity’
Biotech
Investment
Investment
Immorta Bio picked for NYU Stern startup program
Ecosystem
Investment
Investment
The exit math forcing an M&A decade
Biotech
Investment
Investment
Junevity takes gene-network reset into skincare
Investment
Investment
Longevity biotech’s $173 billion in waiting
Ecosystem
Investment
Investment
The $230 billion nobody needs to approve
Biotech
Investment
Investment
BioViva patents dual-gene approach to aging
Investment
Investment
CND Life Sciences opens new neurodiagnostics lab
AI/Digital
Features
Investment
Investment
Oura and Xella connect wearable data to women’s healthspan
Ecosystem
Investment
Investment
Taiwan reframes aging as an economic asset
Ecosystem
Investment
Investment
Longevity biotech’s 100x question
Ecosystem
Investment
Investment
Ovarian aging campaign extends funding push
Ecosystem
Investment
Investment
What is longevity biotech really worth?
Biotech
Ecosystem
Features
Investment
Investment
Research
$617 billion longevity biotech market takes shape
Biotech
Investment
Investment
Magnitude’s worm-powered drug screening lands $1.3m
Biotech
Investment
Investment
Research
Oligomerix puts tau drug in new hands as trials begin
Investment
Investment
HexemBio raises $15.5m to rejuvenate aging stem cells
Biotech
Investment
Investment
Canada agrees to help pay for Alzheimer’s drug LEQEMBI
Ecosystem
Investment
Investment
Research
Your gut just joined the official aging checklist
Investment
Investment
Zomato founder’s startup buys UK-based Longevous
Investment
Investment
GlycanAge teams up with Japan on aging science
Biotech
Investment
Investment
Moonwalk raises $70m for adipose-targeted RNAi
Biotech
Investment
Investment
Rznomics brings RNA editing into Lilly’s San Diego biotech hub
Biotech
Investment
Investment
Celularity lands $300m MuseCell manufacturing deal
Biotech
Investment
Investment
Daewoong wins US patent nod for antiaging mRNA
Investment
Investment
Longevica hires drug-approval veteran as CEO
Biotech
Investment
Investment
Veradermics builds $820m war chest for oral hair loss pill
Investment
Investment
New patent strengthens Alterity’s Parkinson’s investment
Investment
Investment
CND Life Sciences funding backs earlier Parkinson’s detection
Biotech
Investment
Investment
Denali Therapeutics’ brain-crossing drug hits market
Investment
Investment
AlzeCure banks $10m as Lilly deal closes
AI/Digital
Investment
Investment
Network Bio launches with $50m for biological AI
Biotech
Investment
Investment
AlzeCure’s $12m payday fuels new brain-aging therapy
Ecosystem
Investment
Investment
Biological age clocks face a regulatory reckoning
Investment
Investment
Telehealth longevity platform among XPRIZE Healthspan’s top 10
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report